BioSpace News Archive

Press Releases

US FDA Grants Orphan Drug Designation to EXG110, a Novel Gene Therapy for Fabry Disease

December 3, 2024
·
6 min read
Press Releases

MEDIPOST, Inc. Expands U.S. Presence with Key Executive Appointments, advances toward Phase III clinical trial of CARTISTEM® in North America

December 3, 2024
·
3 min read
Press Releases

KBI Biopharma to Lead Development and Manufacturing of Alanis Therapeutics’ Antagonistic Antibody Candidate

December 3, 2024
·
4 min read
Press Releases

Switch Therapeutics Appoints David M. Holtzman, M.D., to Its Scientific Advisory Board and Announces Its First Development Candidate, CASi-APOE, a Liver-Sparing APOE RNAi Therapy

December 3, 2024
·
4 min read
Press Releases

Gate Neurosciences and University of Pittsburgh Collaborate to Initiate Phase 2 Trial Combining Apimostinel with Digital Therapeutic for Depression

December 3, 2024
·
3 min read
Press Releases

Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

December 3, 2024
·
5 min read
Press Releases

Kane Biotech Announces $3,000,000 Private Placement Offering

December 3, 2024
·
3 min read
Press Releases

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

December 3, 2024
·
6 min read
Press Releases

SonoThera Presents New Data at the American Society of Hematology (ASH) Annual Meeting Demonstrating the Potential of Targeted, Ultrasound-Mediated Gene Delivery to Liver

December 3, 2024
·
2 min read
Press Releases

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World’s First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority

December 3, 2024
·
3 min read